4D Molecular Therapeutics, Inc. (FDMT)

Every official 4D Molecular Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports, proxy statements, shareholding and announcements, straight from the regulator. Free to search.

4D Molecular Therapeutics, Inc. documents

• 4D Molecular Therapeutics, Inc. 10-K 2026FDMT 10-K 2026: annual report for fiscal 2026
• 4D Molecular Therapeutics, Inc. 10-K 2025FDMT 10-K 2025: annual report for fiscal 2025
• 4D Molecular Therapeutics, Inc. 10-K 2024FDMT 10-K 2024: annual report for fiscal 2024
• 4D Molecular Therapeutics, Inc. 10-K 2023FDMT 10-K 2023: annual report for fiscal 2023
• 4D Molecular Therapeutics, Inc. 10-K 2022FDMT 10-K 2022: annual report for fiscal 2022
• 4D Molecular Therapeutics, Inc. 10-Q 2026FDMT 10-Q 2026: quarterly report for fiscal 2026
• 4D Molecular Therapeutics, Inc. 10-Q 2025FDMT 10-Q 2025: quarterly report for fiscal 2025
• 4D Molecular Therapeutics, Inc. 10-Q 2024FDMT 10-Q 2024: quarterly report for fiscal 2024
• 4D Molecular Therapeutics, Inc. 10-Q 2023FDMT 10-Q 2023: quarterly report for fiscal 2023
• 4D Molecular Therapeutics, Inc. 10-Q 2022FDMT 10-Q 2022: quarterly report for fiscal 2022
• 4D Molecular Therapeutics, Inc. 8-K 2026FDMT 8-K 2026: current report for fiscal 2026
• 4D Molecular Therapeutics, Inc. 8-K 2025FDMT 8-K 2025: current report for fiscal 2025
• 4D Molecular Therapeutics, Inc. 8-K 2024FDMT 8-K 2024: current report for fiscal 2024
• 4D Molecular Therapeutics, Inc. 8-K 2023FDMT 8-K 2023: current report for fiscal 2023
• 4D Molecular Therapeutics, Inc. 8-K 2022FDMT 8-K 2022: current report for fiscal 2022
• 4D Molecular Therapeutics, Inc. DEF 14A 2026FDMT DEF 14A 2026: proxy statement for fiscal 2026
• 4D Molecular Therapeutics, Inc. DEF 14A 2025FDMT DEF 14A 2025: proxy statement for fiscal 2025
• 4D Molecular Therapeutics, Inc. DEF 14A 2024FDMT DEF 14A 2024: proxy statement for fiscal 2024
• 4D Molecular Therapeutics, Inc. DEF 14A 2023FDMT DEF 14A 2023: proxy statement for fiscal 2023
• 4D Molecular Therapeutics, Inc. DEF 14A 2022FDMT DEF 14A 2022: proxy statement for fiscal 2022
• 4D Molecular Therapeutics, Inc. Form 4 2026FDMT Form 4 2026: insider trading filing for fiscal 2026
• 4D Molecular Therapeutics, Inc. Form 4 2025FDMT Form 4 2025: insider trading filing for fiscal 2025
• 4D Molecular Therapeutics, Inc. Form 4 2024FDMT Form 4 2024: insider trading filing for fiscal 2024
• 4D Molecular Therapeutics, Inc. Form 4 2023FDMT Form 4 2023: insider trading filing for fiscal 2023
• 4D Molecular Therapeutics, Inc. Form 4 2022FDMT Form 4 2022: insider trading filing for fiscal 2022
• 4D Molecular Therapeutics, Inc. S-1 2026FDMT S-1 2026: registration statement for fiscal 2026
• 4D Molecular Therapeutics, Inc. S-1 2025FDMT S-1 2025: registration statement for fiscal 2025
• 4D Molecular Therapeutics, Inc. S-1 2024FDMT S-1 2024: registration statement for fiscal 2024
• 4D Molecular Therapeutics, Inc. S-1 2023FDMT S-1 2023: registration statement for fiscal 2023
• 4D Molecular Therapeutics, Inc. S-1 2022FDMT S-1 2022: registration statement for fiscal 2022
• 4D Molecular Therapeutics, Inc. 13F 2026FDMT 13F 2026: institutional holdings for fiscal 2026
• 4D Molecular Therapeutics, Inc. 13F 2025FDMT 13F 2025: institutional holdings for fiscal 2025
• 4D Molecular Therapeutics, Inc. 13F 2024FDMT 13F 2024: institutional holdings for fiscal 2024
• 4D Molecular Therapeutics, Inc. 13F 2023FDMT 13F 2023: institutional holdings for fiscal 2023
• 4D Molecular Therapeutics, Inc. 13F 2022FDMT 13F 2022: institutional holdings for fiscal 2022

More companies